Editas Medicine, Inc. (EDIT)
3.075
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
3.06
-0.02
(-0.49%)
After-Hours: 20:00
Editas Medicine Cash from Operations (Annual) : -165.24M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -165.24M |
| December 31, 2024 | -210.28M |
| December 31, 2023 | -132.18M |
| December 31, 2022 | -177.35M |
| December 31, 2021 | -163.80M |
| December 31, 2020 | -179.84M |
| Date | Value |
|---|---|
| December 31, 2019 | -40.67M |
| December 31, 2018 | -45.71M |
| December 31, 2017 | -9.417M |
| December 31, 2016 | -50.25M |
| December 31, 2015 | -5.403M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Recursion Pharmaceuticals, Inc. | -371.81M |
| Geron Corp. | -111.04M |
| Halozyme Therapeutics, Inc. | 651.56M |
| Novavax, Inc. | -244.64M |
| AVITA Medical, Inc. | -31.20M |